...BRCA1 levels may mitigate the effect of the mutation. Whether physical activity modulates BRCA1 expression and whether l...
...BRCA1 or 2 mutations. It replaces the previous version of the "Clinical Practice Guideline for the Prevention and Early ...
...BRCA1/2 and NF1 did not show intronic overexpression or truncated splice variants in cancers. These findings emphasize t...
...BRCA1 SS955S, BRCA2 G2508S, and a GNAS inframe insertion. We demonstrated a novel approach to help diagnose and elucidat...
...BRCA1/2 women with familial breast cancer. Putative deleterious mutations were genotyped in relevant family members to a...
...BRCA1/2 mutations (BRCA1/2 carriers: pazopanib 14%, placebo 16%). Median PFS was longer in BRCA1/2 mutation carriers tha...
...BRCA1 was positively correlated with survival duration.,KRAS mutation status and BRCA1 tumour expression are potential b...
...BRCA1, BRCA2, BRIP1, MLH1, MSH2, MSH6, PALB2, PMS2, RAD51D, and RAD51C) and additional candidate genes in DNA repair (AT...
...BRCA1 A complex, and plays a key role in the recruitment process through the binding of Lys(63)-linked poly-Ub chains by...
...BRCA1, BRCA2, p15, p16, p53, and PTEN, and antitumor drug resistance.,DAC treatment caused significant BCSC differentiat...
联系地址
山东省济南市章丘区文博路2号
齐鲁师范学院 genelibs生信实验室
山东省济南市高新区舜华路750号
大学科技园北区F座4单元2楼
电话： 0531-88819269
版权所有 © 2025.Genelibs 济南弘晖生物技术有限公司 鲁ICP备20007159号-2
